New Warnings Added to Labeling of Hepatitis C TreatmentsAschenbrenner, Diane S. MA, RNAJN, American Journal of Nursing: February 2016 - Volume 116 - Issue 2 - p 22 doi: 10.1097/01.NAJ.0000480490.87609.bd Drug Watch Buy Abstract Author InformationAuthors Article MetricsMetrics The combination antiviral therapies Viekira Pak and Technivie, used to treat moderate or severe hepatitis C, can lead to serious liver injury. Nurses should monitor liver values and instruct patients to look for symptoms of liver disease, including fatigue, weakness, a lack of appetite, nausea and vomiting, and jaundice. Diane S. Aschenbrenner was previously the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch: firstname.lastname@example.org. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.